Clinical Trials Logo

Combat Disorders clinical trials

View clinical trials related to Combat Disorders.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02825602 Active, not recruiting - Aging Clinical Trials

Vietnam Era Health Retrospective Observational Study

VE-HEROeS
Start date: July 2016
Phase:
Study type: Observational

The Vietnam Era Health Retrospective Observational Study (VE-HEROeS) is a national study on the health and well-being of Vietnam Veterans, including Blue Water Navy Veterans, as well as Veterans who served elsewhere during the Vietnam Era (1961-1975), and similarly aged U.S. residents who never served in the military. The investigators will invite approximately 43,000 Vietnam and Vietnam Era Veterans, and approximately 11,000 members of the general U.S. population to participate in VE-HEROeS. These individuals are scientifically selected to participate; the study is not able to accept volunteers. All participants in VE-HEROeS will be asked to fill out a questionnaire on their military service, general health, age-related conditions, health care use, and the health experiences of their children and grandchildren. A smaller group will be asked to provide the investigators with access to some of their medical records. Topics of special focus for the study include cognition, hepatitis C infection, and neurologic conditions.

NCT ID: NCT01216982 Active, not recruiting - Depression Clinical Trials

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

Start date: November 2010
Phase: Phase 2
Study type: Interventional

Stress-related disorders are among the most prevalent and expensive medical consequences of participation in military operations. Omega-3 fatty acids EPA/DHA derived from fish oil are known to benefit both neuronal development in the young, and cognition and mood in various populations. It is possible that soldiers receiving Omega-3 EPA/DHA will exhibit significantly higher cognitive performance, better affect/mood state, and less combat stress symptomatology compared to the placebo after 12 weeks of supplementation. A goal would be to reduce the prevalence of combat stress injuries in military personnel.